• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Graphic of a drop of blood made up of small data points and nodes
Biotech

J&J lymphoma CAR-T hits 100% ORR in 10 patients

Of the 10 patients who had received one line of prior treatment, an objective response rate of 100% was recorded.
Darren Incorvaia Jun 13, 2025 1:22pm
hiring new hire

BMS taps biotech analyst to lead long-term strategy

Jun 13, 2025 11:11am
Graphic showing arrows missing the bullseye on a target

How 'overenthusiasm' led to Big Pharma's risky $6B TIGIT gamble

Jun 13, 2025 8:00am
heart model with cardiologist

Atraverse Medical raises $29.4M for left-heart access system

Jun 13, 2025 11:23am
Ozempic syringe pen and measuring tape on blue background

Novo plots ph. 3 trials for next-gen obesity asset amycretin

Jun 13, 2025 10:35am
Dark blue graphic featuring a stylized molecular structure and DNA sequencing patterns in the background The title THE TO

Inside Fierce Medtech's Fierce 15

Jun 13, 2025 8:47am
More News

Sanofi vaccine vet vaults to GSK—Chutes & Ladders

Jun 13, 2025 8:30am

AstraZeneca pens $5.3B pact with CSPC to develop oral drugs

Jun 13, 2025 5:56am

Astellas offers lab space to help Japanese biotechs 'go global'

Jun 13, 2025 4:41am

ADC Therapeutics shutters UK R&D site, lays off 30% of staff

Jun 12, 2025 3:00pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings